S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GRTX Galera Therapeutics Inc (PK)

0.0357

0.00 (0.00%)

Mar 11 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Galera Therapeutics (PK) (USOTC:GRTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Galera Therapeutics (PK) Charts.

Galera Therapeutics (PK) (USOTC:GRTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Galera Therapeutics (PK) Charts.

Galera Therapeutics Inc (PK) News

Form 8-K - Current report
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 14 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Friday 24 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 2 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 20 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 13 December 2024 (3 months ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Friday 15 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 18 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 September 2024 (6 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 3 September 2024 (6 months ago) • Edgar (US Regulatory)

More Galera Therapeutics Inc (PK) News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions